nm23 expression in tissue sections and tumor effusion cells of ovarian neoplasms

International Journal of Cancer

Volumn 69, Issue 5, 1996, Pages 415-419

  Harlozińska, Antonina ^a   Bar, Julia K ^a   Gerber, Jerzy ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

NM 23 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ASCITES FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; OVARY CARCINOMA; PRIORITY JOURNAL; TUMOR CELL; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA, MUCINOUS; ASCITIC FLUID; CARCINOMA, ENDOMETRIOID; CYSTADENOCARCINOMA, SEROUS; FEMALE; FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; MONOMERIC GTP-BINDING PROTEINS; NUCLEOSIDE-DIPHOSPHATE KINASE; OVARIAN NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0029851620     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961021)69:5<415::AID-IJC11>3.0.CO;2-1     Document Type: Article

References (27)

1. BEVILACQUA, G., SOBEL, M.E., LIOTTA, I.A. and STEEG, P.S., Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res., 49, 5185-5190 (1989).
2. CALIGO, M.A., CIPOLLINI, G., FIORE, L., CALVO, S., BASOLO, F., COLLECCHI, P., CIARDlELLO, F., PEPE, S., PETRINI, M. and BEVILACQUA, G., nm23 gene expression correlates with cell growth rate and S-phase. Int. J. Cancer, 60, 837-842 (1995).
3. CHEN, H.C., WANG, L., and BANERJEE, S., Isolation and characterization of the promoter region of human nm23-H1, a metastasis suppressor gene. Oncogene, 9, 2905-2912 (1994).
4. DAWKINS, H.J.S., GOODALL, R.J., HÄHNEL, E., SARNA, M., ROBBINS, P.D., DE KLERK, N.H., HÄHNEL, R., PAPADIMITRIOU, J.M., HARVEY, J.M. and STERRETT, G.F., nm23-H1 metastasis suppressor gene expression in primary breast cancer: associations with axillary lymph node status, tumour size, type and grade. Breast, 2, 239-245 (1993).
5. FIDLER, I.J., Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res., 50, 6130-6138 (1990).
6. FOULKES, W.D., BLACK, D.M., STAMP, G.W.H., SOLOMON, E. and TROWSDALE, J., Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma. Int. J. Cancer, 54, 220-225 (1993).
7. HARLOZIŃSKA, A., BAR, J.K., CISLO, M., RICHTER, R. and RABCZYŃSKI, J., Density distribution and immunological reactivity of tumor cells from peritoneal effusions of patients with ovarian neoplasms. Anal. Cell Pathol., 4, 1-12 (1992).
8. HARLOZIŃSKA, A., BAR, J.K., SEDLACZEK, P. and GERBER, J., Expression of p53 protein and Ki-67 reactivity in ovarian neoplasms. Correlation with histopathology. Amer. J. clin. Pathol, 105, 334-340 (1996).
9. HAUT, M., STEEG, P.S., WILLSON, J.K.V. and MARKOWITZ, S.D., Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. J. nat. Cancer Inst., 83, 712-716 (1991).
10. HENNESSY, C., HENRY, J.A., MAY, F.E.B., WESTLY, B.R., ANGUS, B. and LENNARD, T.W.J., Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J. nat. Cancer Inst., 83, 281-285 (1991).
11. HIRAYAMA, R., SAWAI, S., TAKAGI, Y., MISHIMA, Y., KIMURA, N., SHIMADA, N., ESAKI, Y., KURAJIMA, C. and HIROKAWA, K., Positive relationship between expression of antimetastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer. J. nat. Cancer Inst., 83, 1249-1250 (1991).
12. KODERA, Y., ISOBE, K., YAMAUCHI, M., KONDOH, K., KIMURA, N., AKIYAMA, S., ITOH, K., NAKASHIMA, I. and TAKAGI, H., Expression of nm23 H-l RNA levels in human gastric cancer tissues. A negative correlation with nodal metastasis. Cancer, 73, 259-265 (1994).
13. LEARY, J.A., KERR, J., CHENEVIX-TRENCH, G., DORIS, C.P., HURST, T., HOUGHTON, C.R.S. and FRIEDLANDER, M.L., Increased expression of the NME1 gene is associated with metastasis in epithelial ovarian cancer. Int. J. Cancer, 64, 189-195 (1995).
14. MANDAI, M., KONISHI, I., KOMATSU, T., MORI, T., ARAO, S., NOMURA, H., KANDA, Y., HIAI, H. and FUKUMOTO, M., Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: correlation with tumour progression and nm23 gene expression. Brit. J. Cancer, 72, 691-695 (1995).
15. MANDAI, M., KONISHI, I., KOSHIYAMA, M., MORI, T., ARAO, S., TASHIRO, H., OKAMURA, H., NOMURA, H., HIAI, H. and FUKUMOTO, M., Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Cancer Res., 54, 1825-1830 (1994).
16. NAKAYAMA, H., YASUI, W., YOKOZAKI, H. and TAHARA, E., Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn. J. Cancer Res., 84, 184-190 (1993).
17. NOGUCHI, M., EARASHI, M., OHNISHI, I., KINOSHITA, K., THOMAS, M., FUSIDA, S., MIYAZAKI, I. and MIZUKAMI, Y., nm23 and c-erbB-2 expression in invasive breast cancer. Oncol. Rep., 1, 523-528 (1994).
18. ROYDS, J.A., STEPHENSON, T.J., REES, R.C., SHORTHOUSE, A.J. and SILCOCKS, P.B., nm23 protein expression in ductal in situ and invasive human breast carcinoma. J. nat. Cancer Inst., 85, 727-731 (1993).
19. SASTRE-GARAU, X., LACOMBE, M.L., JOUVE, M., VERON, M. and MAGDALENAT, H., Nucleoside diphosphate kinase/NM23 expression in breast cancer: lack of correlation with lymph-node metastasis. Int. J. Cancer, 50, 533-538 (1992).
20. SAWAN, A., LASCU, I., VERON, M., ANDERSON, J.J., WRIGHT, C., HORNE, C.H.W. and ANGUS, B., NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study. J. Pathol., 172, 27-34 (1994).
21. SHEKHAR, P.V.M., ASLAKSON, C.J. and MILLER, F.R., Molecular events in metastatic progression. Semin. Cancer Biol., 4, 193-204 (1993).
22. SHELLING, A.N., COOKE, I.E. and GANESAN, T.S., The genetic analysis of ovarian cancer. Brit. J. Cancer, 72, 521-527 (1995).
23. SHI, Y., PARHAR, R.S., ZOU, M., AL-SEDAIRY, S. and FARID, N.R., Differential nm23 gene expression at the fetal-maternal interface. Brit. J. Cancer, 70, 440-444 (1994).
24. STAHL, J.A., LEONE, A., ROSENGARD, A.M., PORTER, L., KING, C.R. and STEEG, P.S., Identification of a second human nm23 gene, nm23-H2. Cancer Res., 51, 445-449 (1991).
25. STEEG, P.S., BEVILACQUA, G., KOPPER, L., THORGEIRSSON, U.P., TALMADGE, J.E., LIOTTA, L.A. and SOBEL, M.E., Evidence for a novel gene associated with low tumor metastatic potential. J. nat. Cancer Inst., 80, 200-204 (1988).
26. VIEL, A., DALL'AGNESE, L., CANZONIERI, V., SOPRACORDEVOLE, F., CAPOZZI, E., CARBONE, A., VISENTIN, M.C. and BOIOCCHI, M., Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis. Cancer Res., 55, 2645-2650 (1995).
27. ZENG, Z.S., HSU, S., ZHANG, Z.F., COHEN, A.M., ENKER, W.E., TURNBULL, A.A. and GUILLEM, J.G., High level of nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases. Brit. J. Cancer, 70, 1025-1030 (1994).